Table 3 Area under curve (AUC)

	Olive oil (a)	C4-Dietary oil (b)	Carrot (c)	P value
GLP-1 iAUC	645 ± 194	702 ± 97	7 ± 103	0.002^{a>c, b>c}
GLP-1 tAUC	2,580 ± 204	2,247 ± 115	1,698 ± 115	0.0002^{a>c, b>c}
GIP iAUC	4,338 ± 764	2,894 ± 601	266 ± 234	<0.0001^{a>c, b>c}
GIP tAUC	6,891 ± 1068	4,300 ± 765	2,055 ± 243	<0.0001^{a>b, a>c, b>c}
PYY iAUC	855 ± 1,009	1,402 ± 581	−612 ± 628	0.21
PYY tAUC	13,110 ± 1,526	11,430 ± 1,344	10,650 ± 1,269	0.02^a>c
Glucose iAUC	61 ± 26	172 ± 77	148. ± 38	0.23
Glucose tAUC	1,791 ± 197	1,837 ± 213	1,927 ± 225	0.04^c>a
C-peptide iAUC	66,050 ± 10,800	66,310 ± 9,302	49,130 ± 10,800	0.08
C-peptide tAUC	320,100 ± 20,830	314,000 ± 25,310	324,400 ± 24,840	0.78
Insulin iAUC	8,438 ± 2,222	10,690 ± 1,671	4,901 ± 1,883	0.02^b>c
Insulin tAUC	32,430 ± 2,220	32,580 ± 3,451	33,430 ± 3,378	0.92
Glucagon iAUC	17 ± 104	420 ± 95	18 ± 83	0.005^{b>a, b>c}
Glucagon tAUC	2,513 ± 278	2,556 ± 350	2,292 ± 343	0.11
CCK iAUC	103 ± 34	33 ± 37	−11 ± 22	< 0.01^a>c
CCK tAUC	252 ± 29	229 ± 27	151 ± 19	0.001^{a>c, b>c}
Triglycerides iAUC	12.0 ± 6.8	−4.4 ± 3.9	−7.3 ± 6.0	0.013^{a>b, a>c}
Triglycerides tAUC	240 ± 39	226 ± 27	210 ± 28	0.48
Acetaminophen tAUC	11.7 ± 1.0	13.4 ± 1.2	14.0 ± 1.2	0.02^a<c

Data are mean values ± SEM. All values in pM × min except glucose and triglycerides in mM × min and acetaminophen in µM × min. P values are calculated using repeated measurement ANOVA. P values ≤ 0.05 are considered statistically significant. Statistically significant differences between the three treatments are shown using the letters a, b and c, referring to the treatments
CCK cholecystokinin, GIP glucose-dependent insulinotropic polypeptide (intact), GLP-1 glucagon-like peptide-1 (total), iAUC incremental area under curve, PYY peptide YY, tAUC total area under curve

Search